4DMT | Powering The Future Of Genetic Medicines

4D Molecular Therapeutics designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions.

Melissa Cowan

HR Systems and Operations Manager at 4DMT | Powering The Future Of Genetic Medicines

Crystal Luu

Biomarkers Intern at 4DMT | Powering The Future Of Genetic Medicines

Tamim Assifi

Associate Director Clinical Operations at 4DMT | Powering The Future Of Genetic Medicines

Bum-Yeol Hwang

Senior Scientist at 4DMT | Powering The Future Of Genetic Medicines

Lilian Hu

Senior Clinical Trial Manager at 4DMT | Powering The Future Of Genetic Medicines

Fanny Lau

Senior Accountant at 4DMT | Powering The Future Of Genetic Medicines

Chyong N

Medical Director at 4DMT | Powering The Future Of Genetic Medicines

Catherine Campbell

Vice President, Regulatory Affairs, Quality and GxP Compliance at 4DMT | Powering The Future Of Genetic Medicines

Theresa Janke

Chief Of Staff at 4DMT | Powering The Future Of Genetic Medicines

August Moretti

Board Member at 4DMT | Powering The Future Of Genetic Medicines

Julian Pei

Director, Corporate Finance and FP and A at 4DMT | Powering The Future Of Genetic Medicines

Tandis Vazin

Preclinical and Strategy Consultant and Advisor at 4DMT | Powering The Future Of Genetic Medicines

David Schaffer

Director at 4DMT | Powering The Future Of Genetic Medicines

Vida Mae Fernandez

Administrative Assistant at 4DMT | Powering The Future Of Genetic Medicines

Eric Zheng

4DMT | Powering The Future Of Genetic Medicines

Raja Vakil

Director, Clinical Operations at 4DMT | Powering The Future Of Genetic Medicines